Daniel N. Clark

499 total citations
16 papers, 390 citations indexed

About

Daniel N. Clark is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Daniel N. Clark has authored 16 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Hepatology and 7 papers in Immunology. Recurrent topics in Daniel N. Clark's work include Hepatitis B Virus Studies (8 papers), Hepatitis C virus research (8 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Daniel N. Clark is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Hepatitis C virus research (8 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Daniel N. Clark collaborates with scholars based in United States, Israel and Brazil. Daniel N. Clark's co-authors include Jianming Hu, Brian D. Poole, Timothy B. Niewold, Rafah Salloum, John E. Tavis, Scott A. Jones, Kuancheng Liu, Ju‐Tao Guo, Feng Cao and Xiuji Cui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Frontiers in Immunology.

In The Last Decade

Daniel N. Clark

16 papers receiving 389 citations

Peers

Daniel N. Clark
Daniel N. Clark
Citations per year, relative to Daniel N. Clark Daniel N. Clark (= 1×) peers Fukiko Mitsui

Countries citing papers authored by Daniel N. Clark

Since Specialization
Citations

This map shows the geographic impact of Daniel N. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel N. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel N. Clark more than expected).

Fields of papers citing papers by Daniel N. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel N. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel N. Clark. The network helps show where Daniel N. Clark may publish in the future.

Co-authorship network of co-authors of Daniel N. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel N. Clark. A scholar is included among the top collaborators of Daniel N. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel N. Clark. Daniel N. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Call, Evan, et al.. (2023). Healthcare-Associated Infections and the Hospital Bed. Advances in Skin & Wound Care. 36(10). 1–7. 1 indexed citations
2.
Clark, Daniel N., et al.. (2022). The Effect of Treatment-Associated Mutations on HIV Replication and Transmission Cycles. Viruses. 15(1). 107–107. 8 indexed citations
3.
Clark, Daniel N., et al.. (2021). The hepatitis B virus polymerase. ˜The œEnzymes. 50. 195–226. 8 indexed citations
5.
Clark, Daniel N., Scott A. Jones, & Jianming Hu. (2016). In Vitro Assays for RNA Binding and Protein Priming of Hepatitis B Virus Polymerase. Methods in molecular biology. 1540. 157–177. 6 indexed citations
6.
Clark, Daniel N., John M. Flanagan, & Jianming Hu. (2016). Mapping of Functional Subdomains in the Terminal Protein Domain of Hepatitis B Virus Polymerase. Journal of Virology. 91(3). 17 indexed citations
7.
Clark, Daniel N. & Jianming Hu. (2015). Hepatitis B virus reverse transcriptase – Target of current antiviral therapy and future drug development. Antiviral Research. 123. 132–137. 68 indexed citations
8.
Cui, Xiuji, et al.. (2015). Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes. Journal of Virology. 90(1). 486–496. 39 indexed citations
9.
Clark, Daniel N. & Jianming Hu. (2015). Unveiling the Roles of HBV Polymerase for New Antiviral Strategies. Future Virology. 10(3). 283–295. 39 indexed citations
10.
Clark, Daniel N., et al.. (2013). Molecular Effects of Autoimmune-Risk Promoter Polymorphisms on Expression, Exon Choice, and Translational Efficiency of Interferon Regulatory Factor 5. Journal of Interferon & Cytokine Research. 34(5). 354–365. 6 indexed citations
11.
Clark, Daniel N., et al.. (2013). Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk Polymorphisms. Frontiers in Immunology. 4. 360–360. 24 indexed citations
12.
Jones, Scott A., Daniel N. Clark, Feng Cao, John E. Tavis, & Jianming Hu. (2013). Comparative Analysis of Hepatitis B Virus Polymerase Sequences Required for Viral RNA Binding, RNA Packaging, and Protein Priming. Journal of Virology. 88(3). 1564–1572. 37 indexed citations
13.
Clark, Daniel N., et al.. (2012). Cytokine inhibition as a strategy for treating systemic lupus erythematosus. Clinical Immunology. 148(3). 335–343. 27 indexed citations
14.
Guthridge, Joel M., Daniel N. Clark, Amanda Templeton, et al.. (2012). Effects of IRF5 Lupus Risk Haplotype on Pathways Predicted to Influence B Cell Functions. SHILAP Revista de lepidopterología. 2012. 1–12. 6 indexed citations
15.
Clark, Daniel N., et al.. (2011). Characterization of herpes simplex virus clinical isolate Y3369 as a glycoprotein G variant and its bearing on virus typing. Virology Journal. 8(1). 290–290. 1 indexed citations
16.
Niewold, Timothy B., Daniel N. Clark, Rafah Salloum, & Brian D. Poole. (2010). Interferon Alpha in Systemic Lupus Erythematosus. SHILAP Revista de lepidopterología. 2010. 1–8. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026